Alpine Immune Sciences, Inc.
Leading the Next Evolution of Immunotherapies
99 employees · est. 2015 · Seattle, United States
CRISPR Therapeutics
Gene-based medicines for patients with serious diseases
350 employees · est. 2013 · Boston, United States
CRISPR Therapeutics is the older company (2015 vs 2013); CRISPR Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Alpine Immune Sciences, Inc. | CRISPR Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2013 older |
| Headquarters | ||
| Headquarters | Seattle, United States | Boston, United States |
| Employees | ||
| Employees | 99 | 350 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biopharma, Biotechnology |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | $475.30M | $1.05B |
| Funding Rounds | ||
| Funding Rounds | 7 | 7 |
| Services | ||
| Services | Not tracked yet | Development of gene-based medicines, Gene-editing therapies, Clinical and preclinical research, Patient advocacy |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with serious diseases, Healthcare providers, Biotechnology companies, Research institutions |
| Taxonomy | ||
| Taxonomy | Clinical-stage Biopharmaceutical, Immunotherapy, Autoimmune Diseases, Inflammatory Diseases, Protein-based Therapies, Immune Synapse Targeting, Drug Development, Patented Scientific Platform, ALPN-303, Povetacicept, BAFF Antagonist, APRIL Antagonist, ALPN-101, Acazicolcept, ICOS Antagonist | Gene-based Medicines, CRISPR Technology, Gene Editing, Hematology, Oncology, Regenerative Medicine, Cardiovascular Diseases, Autoimmune Diseases, Rare Diseases, Transfusion-Dependent Beta Thalassemia, Sickle Cell Disease, Biopharmaceuticals, CRISPR/Cas9 Platform, Strategic Partnerships, Nobel Prize-winning Innovations |
| Website | ||
| Website | alpineimmunesciences.com | crisprtx.com |
About Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. is a leading player in the biotechnology and health care industries. Founded in 2015, the company has now become a part of Vertex Pharmaceuticals, a global biotechnology company with a focus on transformative medicines for individuals with serious diseases. Alpine Immune...
About CRISPR Therapeutics
CRISPR Therapeutics, a leader in biopharma and biotechnology, stands at the forefront of creating gene-based medicines for patients with serious diseases. Since its founding in 2013, the company has not only evolved but thrived by leveraging CRISPR technology, a Nobel Prize-winning innovation that h...
We will tell you when either one moves
BounceWatch watches Alpine Immune Sciences, Inc. and CRISPR Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Alpine Immune Sciences... and CRISPR Therapeutics — by email.
Frequently Asked Questions
Compare Alpine Immune Sciences, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Alpine Immune Sciences, Inc. on 11 Sep 2024, and CRISPR Therapeutics on 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
